{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:59:12Z","timestamp":1790456352251,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jneuroim.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T11:55:45Z","timestamp":1542196545000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review"],"prefix":"10.1016","volume":"326","author":[{"given":"M.","family":"Bouxin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schvartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mestrallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Debrumetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hentzien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tabary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bani-Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.11.009_bb0005","first-page":"786","article-title":"Clinical problem solving: a tobacco merchant who can't Spit","volume":"19","author":"Benizri","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000376","article-title":"Opsoclonus-myoclonus syndrome during rituximab treatment for autoimmune autonomic ganglionopathy","volume":"4","author":"Dumitrascu","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autneu.2008.11.013","article-title":"Antibody titers predict clinical features of autoimmune autonomic ganglionopathy","volume":"146","author":"Gibbons","year":"2009","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10286-017-0493-8","article-title":"Seronegative autoimmune autonomic neuropathy: a distinct clinical entity","volume":"28","author":"Golden","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10286-015-0299-5","article-title":"Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy","volume":"25","author":"Gupta","year":"2015","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2010.289","article-title":"Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma","volume":"68","author":"Hollenbeck","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10286-009-0012-7","article-title":"Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab","volume":"19","author":"Imrich","year":"2009","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0040","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e3181a92b52","article-title":"Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy","volume":"72","author":"Iodice","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autneu.2008.11.001","article-title":"Immunotherapy for autoimmune autonomic ganglionopathy","volume":"146","author":"Iodice","year":"2009","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0050","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.10556","article-title":"The spectrum of autoimmune autonomic neuropathies","volume":"53","author":"Klein","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/jnnp.2009.181222","article-title":"Slowly progressive autonomic neuropathy with antiganglionic acetylcholine receptor antibody","volume":"81","author":"Koike","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0060","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/brain\/awq214","article-title":"Clinicopathological features of acute autonomic and sensory neuropathy","volume":"133","author":"Koike","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0065","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00415-012-6458-x","article-title":"The spectrum of clinicopathological features in pure autonomic neuropathy","volume":"259","author":"Koike","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp-2012-302833","article-title":"The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features","volume":"84","author":"Koike","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0075","author":"Mazzeo"},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10286-017-0496-5","article-title":"Autoimmune autonomic neuropathies: time to look beyond autoimmune autonomic ganglionopathy","volume":"28","author":"Muppidi","year":"2018","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cen3.12137","article-title":"Combined immunomodulatory therapies resulted in stepwise recovery in autoimmune autonomic ganglionopathy","volume":"6","author":"Nishihara","year":"2015","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.61.1.44","article-title":"Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody","volume":"61","author":"Sandroni","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0095","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated composite autonomic symptom score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2018.03.018","article-title":"Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): same clinical picture, same response to immunotherapy","volume":"319","author":"Tijero","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0105","series-title":"Auton Neurosci","first-page":"1","volume":"146","author":"Vernino","year":"2009"},{"key":"10.1016\/j.jneuroim.2018.11.009_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2008.09.005","article-title":"Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy","volume":"146","author":"Vernino","year":"2009","journal-title":"Auton. Neurosci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818304788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818304788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:13:38Z","timestamp":1790453618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818304788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":22,"alternative-id":["S0165572818304788"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.11.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}